The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Amsalyo 75 mg powder for concentration for solution infusion



Eurocept International BVPA1591/003/001

Main Information

Trade NameAmsalyo 75 mg powder for concentration for solution infusion
Active SubstancesAmsacrine
Dosage FormPowder for solution for infusion
Licence HolderEurocept International BV
Licence NumberPA1591/003/001

Group Information

ATC CodeL01XX01 amsacrine

Status

License statusAuthorised
Licence Issued26/01/2024
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back